Vertex nabs ViaCyte’s rival diabetes stem cell treatment, acquiring the biotech for $ 320M in cash – Endpoints News

Days after President Joe Biden signed an executive order directing HHS to expand access to birth control, HRA Pharma filed an application to become the first FDA-approved contraceptive pill available over the counter.

HRA Pharma, which was recently acquired by Dublin-based Perrigo for more than $ 2 billion, has filed to make its daily progestin-only Opill available without a prescription.

“This historic application marks a groundbreaking moment in contraceptive access and equity,” HRA’s chief strategic operations and innovation officer Frédérique Welgryn said in a news release. “Moving a safe and effective prescription birth control pill to OTC will help even more women and people access contraception without facing unnecessary barriers.”

Keep reading Endpoints with a free subscription

Unlock this story instantly and join 145,200+ biopharma pros reading Endpoints daily – and it’s free.

Leave a Comment

Your email address will not be published.

%d bloggers like this: